Profile picture

Doctor Riccardo Perfetti

New York (United States of America)
Follow
Logo ESC

Contributor content

Diabetic Cardiomyopathy: baseline Characteristics of patients enrolled into the ARISE-HF trial
Presentation
Diabetic Cardiomyopathy: baseline Characteristics of patients enrolled into the ARISE-HF trial
Read more
Beneficial effects of AT-001, an aldose reductase inhibitor, in rodent models of diabetic cardiomyopathy
Presentation
Beneficial effects of AT-001, an aldose reductase inhibitor, in rodent models of diabetic cardiomyopathy
Read more
Safety and proof of biological activity support clinical development of AT-001 for diabetic cardiomyopathy: a phase 1/2 study
Presentation
Safety and proof of biological activity support clinical development of AT-001 for diabetic cardiomyopathy: a phase 1/2 study
Read more

ESC 365 is supported by

novartis Explore sponsored resources